{"id":"NCT02203032","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-07","primaryCompletion":"2015-12-25","completion":"2016-05-24","firstPosted":"2014-07-29","resultsPosted":"2017-07-17","lastUpdate":"2017-09-12"},"enrollment":872,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"Ustekinumab","otherNames":[]},{"type":"DRUG","name":"Guselkumab","otherNames":[]},{"type":"DRUG","name":"Placebo for ustekinumab","otherNames":[]},{"type":"DRUG","name":"Placebo for guselkumab","otherNames":[]}],"arms":[{"label":"Open-label ustekinumab","type":"EXPERIMENTAL"},{"label":"Double-blind guselkumab","type":"EXPERIMENTAL"},{"label":"Double-blind ustekinumab","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of guselkumab (CNTO 1959) in the treatment of participants with moderate to severe plaque-type psoriasis (scaly skin rash) who had inadequate response to ustekinumab.","primaryOutcome":{"measure":"Number of Visits at Which Participants Achieved an Investigator's Global Assessment (IGA) Response of Cleared (0) or Minimal (1) and at Least a 2 Grade Improvement (From Week 16) From Week 28 Through Week 40","timeFrame":"Week 28 through Week 40","effectByArm":[{"arm":"Guselkumab (Randomized)","deltaMin":1.5,"sd":1.57},{"arm":"Ustekinumab (Randomized)","deltaMin":0.7,"sd":1.26}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":85,"countries":["United States","Australia","Canada","Germany","Poland","Russia","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["37906417","37071038"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":871},"commonTop":["Nasopharyngitis","Upper Respiratory Tract Infection"]}}